A combined experimental and in silico characterization to highlight additional structural features and properties of a potentially new drug-Reference-Cited by-同舟云学术

A combined experimental and in silico characterization to highlight additional structural features and properties of a potentially new drug

Published:2017-10 Issue: Volume:1146 Page:735-743
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Bastos Isadora T.S.^ORCID,Costa Fanny N.,Silva Tiago F.,Barreiro Eliezer J.^ORCID,Lima Lídia M.,Braz Delson,Lombardo Giuseppe M.,Punzo Francesco^ORCID,Ferreira Fabio F.^ORCID,Barroso Regina C.

Funder

CAPES

INCT-INOFAR

National Council for Scientific and Technological Development

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference59 articles.

1. Química Medicinal - As Bases Moleculares da Ação dos Fármacos;Barreiro,2008

2. The Practice of Medicinal Chemistry;Wermuth,2008

3. Privileged structures: a useful concept for the rational design of new lead drug candidates;Duarte;Mini Rev. Med. Chem.,2007

4. Planejamento, síntese e avaliação farmacológica de uma nova série de derivados cicloalquil-N-acilidrazônicos: análogos de LASSBio-294;Silva,2012

5. Thienylhydrazon with Digitalis-like Properties (Positive Inotropic Effects);Sudo,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Force field and quantum mechanical study of 3-aminopropyltriethoxy silane sorption on hydroxyl free yttria surface;Computational and Theoretical Chemistry;2024-08

2. Design and Synthesis In Silico Drug-like Prediction and Pharmacological Evaluation of Cyclopolymethylenic Homologous of LASSBio-1514;Molecules;2021-08-10

3. Design, Synthesis, Experimental and Theoretical Characterization of a New Multitarget 2-Thienyl-N-Acylhydrazone Derivative;Pharmaceuticals;2018-11-01

4. Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2018-01-01